Idiopathic pulmonary fibrosis was associated with 67,843 deaths in ever-employed persons in the US between 2020 and 2022.

Ipilimumab, a cancer immunotherapy, reduced scar formation and promoted tissue regeneration in a mouse model of idiopathic ...